Study Reveals Risks of Infrequent Cannabis Use in Adolescents
Infrequent adolescent cannabis use risks include measurable declines in academic performance and mental health outcomes. This study challenges assumptions about safe cannabis use thresholds in youth. Clinicians should counsel families that even…
Review of Cannabinoids Safety and Efficacy in Pediatric Care
This review focuses on cannabinoids pediatric safety efficacy in clinical use, highlighting condition-specific evidence. Research supports cautious use in epilepsy and pain management among children. Clinicians should consider evolving data to guide…
Limits of THC Blood Testing in Cannabis Clinical Updates 2026
This digest highlights the limits of THC blood testing in clinical and forensic settings, emphasizing its inadequacy for impairment assessment. It also covers cannabinoid hyperemesis syndrome and prenatal cannabis exposure risks. These topics are…
Cannabinoid Hyperemesis Syndrome Children: Clinical Awareness
Cannabinoid hyperemesis syndrome children represent a critical clinical concern requiring systematic screening in cannabis users. Prenatal cannabis exposure risks demand patient counseling in reproductive care. The expanding endocannabinoid system…
Marijuana Use & Dangers for Adolescents & Young Adults
Marijuana use adolescent mental health risks are significant due to the brain's ongoing development into the mid-twenties. Regular cannabis use during adolescence can accelerate mental health problems requiring professional care. Understanding these…
DPH Commissioner on Measles Outbreaks and Cannabis Potency
Cannabis potency restrictions could affect patient access to high-concentration products needed for therapeutic efficacy. State health authorities consider new labeling and potency regulations. Clinicians must prepare for dosing adjustments amid evolving…
Study Links Prenatal Cannabis Exposure to Schizophrenia Risk
Emerging research on prenatal cannabis exposure schizophrenia risk reveals biological signatures in placental tissue linked to increased schizophrenia risk in offspring. The placenta mediates fetal neurodevelopment during critical brain formation…
Psychiatric Vulnerability Adolescent Cannabis Risks
This cycle’s coverage highlights psychiatric vulnerability adolescent cannabis risks, emphasizing young brains exposed to high-potency THC. Cannabis use links to anxiety and depression require careful interpretation. Regulatory decisions may undermine…
Placental Gene Expression Changes From Prenatal Cannabis Exposure Indicate Schizophrenia Risk
Prenatal cannabis exposure placental gene expression changes may indicate increased schizophrenia risk in offspring. Emerging research shows epigenetic disruptions in placental tissue linked to neurodevelopmental pathways. This highlights the placenta's…
Harm Reduction Cannabis Policy: Addressing Gaps & Risks
This daily digest highlights harm reduction cannabis policy focusing on adolescent brain risk and the policy patchwork. It synthesizes 20 recent articles emphasizing clinical context and regulatory challenges. Harm reduction cannabis policy remains…
